Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

Goldstein EJ, Solomkin JS, Citron DM, Alder JD.

Clin Infect Dis. 2011 Dec;53(11):1074-80. doi: 10.1093/cid/cir664. Epub 2011 Oct 12.

PMID:
21998288
2.

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.

Anastasiou DM, Morgan M, Ruane PJ, Steenbergen JN, Katz BD, Alder JD, Thorne GM.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):339-42. doi: 10.1016/j.diagmicrobio.2008.01.012. Epub 2008 Mar 4.

PMID:
18304772
3.

Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.

Mascio CT, Alder JD, Silverman JA.

Antimicrob Agents Chemother. 2007 Dec;51(12):4255-60. Epub 2007 Oct 8.

4.

Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.

Mortin LI, Li T, Van Praagh AD, Zhang S, Zhang XX, Alder JD.

Antimicrob Agents Chemother. 2007 May;51(5):1787-94. Epub 2007 Feb 16.

5.

In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.

Anastasiou DM, Thorne GM, Luperchio SA, Alder JD.

Int J Antimicrob Agents. 2006 Nov;28(5):385-8. Review.

PMID:
17046205
6.

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.

Friedman L, Alder JD, Silverman JA.

Antimicrob Agents Chemother. 2006 Jun;50(6):2137-45.

7.

Daptomycin: a new drug class for the treatment of Gram-positive infections.

Alder JD.

Drugs Today (Barc). 2005 Feb;41(2):81-90. Review.

PMID:
15821781
8.

New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.

Szczepankiewicz BG, Liu G, Jae HS, Tasker AS, Gunawardana IW, von Geldern TW, Gwaltney SL 2nd, Wu-Wong JR, Gehrke L, Chiou WJ, Credo RB, Alder JD, Nukkala MA, Zielinski NA, Jarvis K, Mollison KW, Frost DJ, Bauch JL, Hui YH, Claiborne AK, Li Q, Rosenberg SH.

J Med Chem. 2001 Dec 6;44(25):4416-30.

PMID:
11728187
9.

Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.

Mitten MJ, Meulbroek J, Nukkala M, Paige L, Jarvis K, Oleksijew A, Tovcimak A, Hernandez L, Alder JD, Ewing P, Or YS, Ma Z, Nilius AM, Mollison K, Flamm RK.

Antimicrob Agents Chemother. 2001 Sep;45(9):2585-93.

10.

Identification and characterization of A-105972, an antineoplastic agent.

Wu-Wong JR, Alder JD, Alder L, Burns DJ, Han EK, Credo B, Tahir SK, Dayton BD, Ewing PJ, Chiou WJ.

Cancer Res. 2001 Feb 15;61(4):1486-92.

11.

Total synthesis and antifungal evaluation of cyclic aminohexapeptides.

Klein LL, Li L, Chen HJ, Curty CB, DeGoey DA, Grampovnik DJ, Leone CL, Thomas SA, Yeung CM, Funk KW, Kishore V, Lundell EO, Wodka D, Meulbroek JA, Alder JD, Nilius AM, Lartey PA, Plattner JJ.

Bioorg Med Chem. 2000 Jul;8(7):1677-96.

PMID:
10976515
12.

Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 position.

Ma Z, Chu DT, Cooper CS, Li Q, Fung AK, Wang S, Shen LL, Flamm RK, Nilius AM, Alder JD, Meulbroek JA, Or YS.

J Med Chem. 1999 Oct 7;42(20):4202-13.

PMID:
10514290
13.

In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains.

Oleksijew A, Meulbroek J, Ewing P, Jarvis K, Mitten M, Paige L, Tovcimak A, Nukkula M, Chu D, Alder JD.

Antimicrob Agents Chemother. 1998 Oct;42(10):2674-7.

14.

Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection.

Alder JD, Ewing PJ, Nilius AM, Mitten M, Tovcimak A, Oleksijew A, Jarvis K, Paige L, Tanaka SK.

Antimicrob Agents Chemother. 1998 Sep;42(9):2385-90.

15.

Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.

Alder JD, Ewing PJ, Mitten MJ, Oleksijew A, Tanaka SK.

Am J Gastroenterol. 1996 Nov;91(11):2347-54.

PMID:
8931416
16.
17.

Model of Streptococcus pneumoniae meningitis in adult rats.

Strake JG, Mitten MJ, Ewing PJ, Alder JD.

Lab Anim Sci. 1996 Oct;46(5):524-9.

PMID:
8905585
18.

Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours.

Alder JD, Jarvis KP, Marsh KC, Klein LL, Clement JJ.

Br J Cancer. 1996 Mar;73(5):560-4.

19.

Enteral formula composition does not affect response to lethal infectious challenge in mice.

Alder JD, Meulbroek J, Jarvis K, Mitten M, Hutch T Sr, Paige L, Shipkowitz N, Henningfield MF, Clement J.

J Nutr. 1994 Nov;124(11):2156-62.

PMID:
7965199
20.

Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi.

Kenefick KB, Lim LC, Alder JD, Schmitz JL, Czuprynski CJ, Schell RF.

J Infect Dis. 1993 May;167(5):1086-92.

PMID:
8486941
21.

Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete.

Lovrich SD, Callister SM, Schmitz JL, Alder JD, Schell RF.

Infect Immun. 1991 Aug;59(8):2522-8.

22.

Role of L3T4+ and 38+ T-cell subsets in resistance against infection with Treponema pallidum subsp. pertenue in hamsters.

Liu H, Alder JD, Steiner BM, Stein-Streilein J, Lim L, Schell RF.

Infect Immun. 1991 Feb;59(2):529-36.

23.
24.

Phagocytosis of opsonized Treponema pallidum subsp. pallidum proceeds slowly.

Alder JD, Friess L, Tengowski M, Schell RF.

Infect Immun. 1990 May;58(5):1167-73.

25.

Phagocytosis of Treponema pallidum pertenue by hamster macrophages on membrane filters.

Alder JD, Daugherty N, Harris ON, Liu H, Steiner BM, Schell RF.

J Infect Dis. 1989 Aug;160(2):289-97.

PMID:
2668423
26.

Immune complexes in serum of rats during infection with Plasmodium berghei.

Alder JD, Kreier JP.

Parasitol Res. 1989;76(2):119-26.

PMID:
2515536
27.

Synergistic effect of macrophage activation and immune serum, especially IgG2, on resistance to infection with Treponema pallidum ssp. endemicum in hamsters.

Azadegan AA, Schell RF, Alder JD, Steiner BM, Liu H, Harris ON, Coe JE.

Reg Immunol. 1988 Jul-Aug;1(1):3-8.

PMID:
3152775
28.
29.

Effects of immune complexes on immunity to Plasmodium berghei infection.

Alder JD, Kreier JP.

Tropenmed Parasitol. 1984 Dec;35(4):253-9.

PMID:
6395456

Supplemental Content

Loading ...
Support Center